Published in Am J Transplant on February 25, 2010
Association of distance from a transplant center with access to waitlist placement, receipt of liver transplantation, and survival among US veterans. JAMA (2014) 1.95
Outcomes of adult living donor liver transplantation: comparison of the Adult-to-adult Living Donor Liver Transplantation Cohort Study and the national experience. Liver Transpl (2011) 1.09
Validating posttransplant hepatocellular carcinoma recurrence data in the United Network for Organ Sharing database. Liver Transpl (2013) 1.02
Design and methodology of the Swiss Transplant Cohort Study (STCS): a comprehensive prospective nationwide long-term follow-up cohort. Eur J Epidemiol (2013) 0.91
Underreporting of liver transplant waitlist removals due to death or clinical deterioration: results at four major centers. Transplantation (2013) 0.89
Program-specific reports: implications and impact on program behavior. Curr Opin Organ Transplant (2013) 0.89
Post-liver transplantation sarcopenia in cirrhosis: a prospective evaluation. J Gastroenterol Hepatol (2014) 0.89
Post-transplant survival is improved for hepatitis C recipients who are RNA negative at time of liver transplantation. Transpl Int (2015) 0.87
Quality of life, risk assessment, and safety research in liver transplantation: new frontiers in health services and outcomes research. Curr Opin Organ Transplant (2012) 0.87
Defining long-term outcomes with living donor liver transplantation in North America. Ann Surg (2015) 0.82
How regenerative medicine and tissue engineering may complement the available armamentarium in gastroenterology? World J Gastroenterol (2012) 0.80
Validating Early Post-Transplant Outcomes Reported for Recipients of Deceased Donor Kidney Transplants. Clin J Am Soc Nephrol (2015) 0.79
Outcomes of living versus deceased donor liver transplantation for acute liver failure in the United States. Transplant Proc (2014) 0.78
Acute Rejection Increases Risk of Graft Failure and Death in Recent Liver Transplant Recipients. Clin Gastroenterol Hepatol (2016) 0.77
Live liver donors' risk thresholds: risking a life to save a life. HPB (Oxford) (2013) 0.77
Liver transplant recipients with portal vein thrombosis receiving an organ from a high-risk donor are at an increased risk for graft loss due to hepatic artery thrombosis. Transpl Int (2016) 0.75
Spontaneous bacterial peritonitis prevalence in pre-transplant patients and its effect on survival and graft loss post-transplant. World J Hepatol (2016) 0.75
Transplant data collection: you get what you pay for. Am J Transplant (2010) 0.75
A critical look at methods for handling missing covariates in epidemiologic regression analyses. Am J Epidemiol (1995) 9.27
Survival benefit-based deceased-donor liver allocation. Am J Transplant (2009) 2.89
Improvement in survival associated with adult-to-adult living donor liver transplantation. Gastroenterology (2007) 2.72
Outcomes of 385 adult-to-adult living donor liver transplant recipients: a report from the A2ALL Consortium. Ann Surg (2005) 2.64
Analytical methods and database design: implications for transplant researchers, 2005. Am J Transplant (2006) 2.14
Improving liver allocation: MELD and PELD. Am J Transplant (2004) 2.14
Donor morbidity after living donation for liver transplantation. Gastroenterology (2008) 1.90
Recipient morbidity after living and deceased donor liver transplantation: findings from the A2ALL Retrospective Cohort Study. Am J Transplant (2008) 1.69
Mycophenolate mofetil use is associated with decreased risk of late acute rejection in adult liver transplant recipients. Am J Transplant (2006) 1.66
Outcomes of donor evaluation in adult-to-adult living donor liver transplantation. Hepatology (2007) 1.31
Transplant data: sources, collection and research considerations, 2004. Am J Transplant (2005) 1.22
Immunosuppression: evolution in practice and trends, 1993-2003. Am J Transplant (2005) 1.17
Incidence and severity of acute cellular rejection in recipients undergoing adult living donor or deceased donor liver transplantation. Am J Transplant (2008) 1.13
Agreement of immunosuppression regimens described in Medicare pharmacy claims with the Organ Procurement and Transplantation Network survey. J Am Soc Nephrol (2006) 1.13
Linking the US transplant registry to administrative claims data: expanding the potential of transplant research. Med Care (2007) 1.09
Novel methods for tracking long-term maintenance immunosuppression regimens. Clin J Am Soc Nephrol (2007) 1.04
Mycophenolate mofetil combination therapy improves long-term outcomes after liver transplantation in patients with and without hepatitis C. Liver Transpl (2005) 0.93
Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. N Engl J Med (1999) 15.69
Structure of yeast phenylalanine tRNA at 3 A resolution. Nature (1974) 10.27
New rapid gel sequencing method for RNA. Nature (1977) 9.56
Characteristics associated with liver graft failure: the concept of a donor risk index. Am J Transplant (2006) 8.03
Structure of nucleosome core particles of chromatin. Nature (1977) 6.24
Molecular switch for signal transduction: structural differences between active and inactive forms of protooncogenic ras proteins. Science (1990) 5.76
The primary structure of transcription factor TFIIIA has 12 consecutive repeats. FEBS Lett (1985) 4.73
Association of diabetes mellitus and chronic hepatitis C virus infection. Hepatology (1999) 4.59
Structure of yeast phenylalanine transfer RNA at 2.5 A resolution. Proc Natl Acad Sci U S A (1975) 4.57
Structural basis for signal transduction by the Toll/interleukin-1 receptor domains. Nature (2000) 4.36
Structure of Sindbis virus core protein reveals a chymotrypsin-like serine proteinase and the organization of the virion. Nature (1991) 4.24
The crystal structure of EcoRV endonuclease and of its complexes with cognate and non-cognate DNA fragments. EMBO J (1993) 4.11
Three-dimensional structure of an oncogene protein: catalytic domain of human c-H-ras p21. Science (1988) 3.99
Crystal structure of dimeric HIV-1 capsid protein. Nat Struct Biol (1996) 3.93
Outcomes of stroke patients in Medicare fee for service and managed care. JAMA (1997) 3.91
A crystallographic study of metal-binding to yeast phenylalanine transfer RNA. J Mol Biol (1977) 3.71
Protein factors in pre-mRNA 3'-end processing. Cell Mol Life Sci (2008) 3.44
Estimating hospital costs. A multiple-output analysis. J Health Econ (1986) 3.09
Report of a National Conference on Donation after cardiac death. Am J Transplant (2006) 3.04
Survival benefit-based deceased-donor liver allocation. Am J Transplant (2009) 2.89
Hereditary renal-cell carcinoma associated with a chromosomal translocation. N Engl J Med (1979) 2.82
Resource utilization in liver transplantation: effects of patient characteristics and clinical practice. NIDDK Liver Transplantation Database Group. JAMA (1999) 2.78
Current methods of transfer of young people with Type 1 diabetes to adult services. Diabet Med (2002) 2.76
Structural basis for self-association and receptor recognition of human TRAF2. Nature (1999) 2.74
Improvement in survival associated with adult-to-adult living donor liver transplantation. Gastroenterology (2007) 2.72
Further refinement of the structure of yeast tRNAPhe. J Mol Biol (1978) 2.71
Outcomes of 385 adult-to-adult living donor liver transplant recipients: a report from the A2ALL Consortium. Ann Surg (2005) 2.64
Survival outcomes following liver transplantation (SOFT) score: a novel method to predict patient survival following liver transplantation. Am J Transplant (2008) 2.63
Degradation of collagen by a human granulocyte collagenolytic system. J Clin Invest (1968) 2.62
The Wiskott-Aldrich syndrome. A disorder with a possible defect in antigen processing or recognition. Lancet (1968) 2.61
Effect of waiting time on renal transplant outcome. Kidney Int (2000) 2.57
Structural basis for inhibition of the cyclin-dependent kinase Cdk6 by the tumour suppressor p16INK4a. Nature (1998) 2.52
The survival benefit of deceased donor liver transplantation as a function of candidate disease severity and donor quality. Am J Transplant (2008) 2.48
Current trends in colorectal cancer: site, incidence, mortality and survival in England and Wales. Clin Oncol (R Coll Radiol) (2001) 2.41
Hodgkin's disease. Immunologic, clinical, and histologic features of 50 untreated patients. Ann Intern Med (1967) 2.38
Organ donation and utilization in the United States, 1999-2008. Am J Transplant (2010) 2.33
Leptin concentrations in the United States: relations with demographic and anthropometric measures. Am J Clin Nutr (2001) 2.31
Crystallographic and biochemical investigation of the lead(II)-catalyzed hydrolysis of yeast phenylalanine tRNA. Biochemistry (1985) 2.22
Association of diabetes, serum insulin, and C-peptide with gallbladder disease. Hepatology (2000) 2.19
Outdoor activity and myopia in Singapore teenage children. Br J Ophthalmol (2009) 2.13
Cyclosporine: five years' experience in cadaveric renal transplantation. N Engl J Med (1984) 2.10
Alfentanil for conscious sedation during colonoscopy. South Med J (1995) 2.07
Relief of uremic pruritus with ultraviolet phototherapy. N Engl J Med (1977) 2.06
Liver and intestine transplantation in the United States, 1997-2006. Am J Transplant (2008) 2.04
Adjuvant chemotherapy improves survival after liver transplantation for hepatocellular carcinoma. Ann Surg (1995) 2.03
Donation after cardiac death liver transplantation: predictors of outcome. Am J Transplant (2010) 2.02
American Society of Transplant Surgeons transplant center outcomes requirements--a threat to innovation. Am J Transplant (2009) 2.00
Characterization and sequence analysis of a developmentally regulated putative cell wall protein gene isolated from soybean. J Biol Chem (1987) 1.99
A model for the tertiary structure of the 28 residue DNA-binding motif ('zinc finger') common to many eukaryotic transcriptional regulatory proteins. Protein Eng (1988) 1.98
Atomic co-ordinates for yeast phenylalanine tRNA. Nucleic Acids Res (1975) 1.98
Pb(II)-catalysed cleavage of the sugar-phosphate backbone of yeast tRNAPhe--implications for lead toxicity and self-splicing RNA. Nature (1983) 1.92
Long-term remission of chronic hepatitis B after alpha-interferon therapy. Ann Intern Med (1991) 1.92
COMO: a program for combined molecular replacement. Acta Crystallogr D Biol Crystallogr (2001) 1.91
Donor morbidity after living donation for liver transplantation. Gastroenterology (2008) 1.90
Recommendations for the outpatient surveillance of renal transplant recipients. American Society of Transplantation. J Am Soc Nephrol (2000) 1.90
X-ray diffraction study of a new crystal form of the nucleosome core showing higher resolution. J Mol Biol (1981) 1.81
Fatty liver indices in the multiethnic United States National Health and Nutrition Examination Survey. Aliment Pharmacol Ther (2014) 1.79
Graft and patient survival in kidney transplant recipients selected for de novo steroid-free maintenance immunosuppression. Am J Transplant (2008) 1.75
A novel cold-inducible zinc finger protein from soybean, SCOF-1, enhances cold tolerance in transgenic plants. Plant J (2001) 1.74
First-pass metabolism of cyclosporin by the gut. Lancet (1991) 1.71
Hepatocellular carcinoma recurrence and death following living and deceased donor liver transplantation. Am J Transplant (2007) 1.70
Recipient morbidity after living and deceased donor liver transplantation: findings from the A2ALL Retrospective Cohort Study. Am J Transplant (2008) 1.69
Recovery and utilization of deceased donor kidneys from small pediatric donors. Am J Transplant (2006) 1.68
Human granulocyte collagenase. Science (1968) 1.68
Differing roles for zinc fingers in DNA recognition: structure of a six-finger transcription factor IIIA complex. Proc Natl Acad Sci U S A (1998) 1.67
Impact of virologic breakthrough and HBIG regimen on hepatitis B recurrence after liver transplantation. Am J Transplant (2010) 1.67
The economic impact of the utilization of liver allografts with high donor risk index. Am J Transplant (2007) 1.67
Fluorodeoxyglucose uptake in human cancer cell lines is increased by hypoxia. J Nucl Med (1995) 1.67
The home health visit: an appropriate unit for Medicare payment? Health Aff (Millwood) (1996) 1.67
CYP3A gene expression in human gut epithelium. Pharmacogenetics (1994) 1.66
Mechanism of tumorigenesis of renal carcinomas associated with the constitutional chromosome 3;8 translocation. Cancer J Sci Am (2006) 1.64
Molecular mechanism for dimerization to regulate the catalytic activity of human cytomegalovirus protease. Nat Struct Biol (2001) 1.64
Correlation between donor age and the pattern of liver graft recovery after transplantation. Transplantation (1995) 1.63
Clinical relevance of thyroid-stimulating autoantibodies in pediatric graves' disease-a multicenter study. J Clin Endocrinol Metab (2014) 1.63
Fatal Clostridium difficile enteritis after total abdominal colectomy. J Clin Gastroenterol (1996) 1.63
Geographic differences in event rates by model for end-stage liver disease score. Am J Transplant (2006) 1.62
Selection for and outcome of liver transplantation in alcoholic liver disease. Gastroenterology (1992) 1.62
Structural basis of inhibition of CDK-cyclin complexes by INK4 inhibitors. Genes Dev (2000) 1.62
Function of Rta is essential for lytic replication of murine gammaherpesvirus 68. J Virol (2001) 1.61
Myxococcus xanthus dif genes are required for biogenesis of cell surface fibrils essential for social gliding motility. J Bacteriol (2000) 1.61
Kallmann syndrome: MR findings. AJNR Am J Neuroradiol (1993) 1.60
Current treatment modalities for hepatocellular carcinoma. Ann Surg (1994) 1.59
Fingers and helices. Nature (1987) 1.59
Outcomes in hepatitis C virus-infected recipients of living donor vs. deceased donor liver transplantation. Liver Transpl (2007) 1.58
Correlation between three-dimensional structure and chemical reactivity of transfer RNA. Nucleic Acids Res (1974) 1.58
The riskiest job in medicine: transplant surgeons and organ procurement travel. Am J Transplant (2009) 1.58
Randomized controlled trial of hand-assisted laparoscopic versus open surgical live donor nephrectomy. Transplantation (2001) 1.58
De novo sirolimus and reduced-dose tacrolimus versus standard-dose tacrolimus after liver transplantation: the 2000-2003 phase II prospective randomized trial. Am J Transplant (2014) 1.57
Endoscopic management of postoperative biliary complications in orthotopic liver transplantation. Gastrointest Endosc (2000) 1.57
Limiting hepatitis C virus progression in liver transplant recipients using sirolimus-based immunosuppression. Am J Transplant (2011) 1.56
A double-blind, randomized, placebo-controlled trial of prostaglandin E1 in liver transplantation. Hepatology (1995) 1.56
Prevalence of thyroid deficiency in pregnant women. Clin Endocrinol (Oxf) (1991) 1.56
Preoperative risk factor assessment in liver transplantation. Surgery (1992) 1.55
Comprehensive evaluation of isoprenoid biosynthesis regulation in Saccharomyces cerevisiae utilizing the Genome Reporter Matrix. J Lipid Res (1999) 1.54
Transmission of hepatitis B by transplantation of livers from donors positive for antibody to hepatitis B core antigen. The National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database. Gastroenterology (1997) 1.54